Hong Kong Baptist University

Entertainment Expo Hong Kong kicks off

Retrieved on: 
星期五, 三月 1, 2024

HONG KONG, Mar 1, 2024 - (ACN Newswire) - The 20th edition of the Entertainment Expo Hong Kong, which is being held from 24 February to 14 April, promises to be an arts and culture extravaganza showcasing the best of Hong Kong film, television, music and digital entertainment across 10 events.

Key Points: 
  • HONG KONG, Mar 1, 2024 - (ACN Newswire) - The 20th edition of the Entertainment Expo Hong Kong, which is being held from 24 February to 14 April, promises to be an arts and culture extravaganza showcasing the best of Hong Kong film, television, music and digital entertainment across 10 events.
  • The annual Expo attracts international stars, directors and entertainment industry elites to Hong Kong and is pleased to announce Leon Lai as this year's Expo ambassador.
  • Alongside the three founding events, Hong Kong International Film and TV Market, Hong Kong International Film Festival, and Hong Kong Film Awards, seven core programmes will showcase Hong Kong's status as a leading business hub for the creative industries in Asia.
  • Organised by the Hong Kong Trade Development Council (HKTDC), the Expo is sponsored by Create Hong Kong (CreateHK), the Film Development Fund and the Culture, Sports and Tourism Bureau of the Hong Kong SAR.

HKBU research suggests potential of artemisinin derivative in treating human obesity

Retrieved on: 
星期四, 三月 7, 2024

This is the first time that artesunate is demonstrated to be able to treat obesity in a non-human primate, suggesting its therapeutic potential as a drug for treating human obesity.

Key Points: 
  • This is the first time that artesunate is demonstrated to be able to treat obesity in a non-human primate, suggesting its therapeutic potential as a drug for treating human obesity.
  • However, patient compliance with exercise and dietary changes is often challenging, and many anti-obesity drugs are associated with adverse effects.
  • The researchers explored the therapeutic effect of artesunate on obesity using mice with diet-induced obesity.
  • "The research results provide hope for developing a novel treatment agent in response to the public health challenge of obesity, which warrants more extensive and effective interventions," he added.

HKBU research suggests potential of artemisinin derivative in treating human obesity

Retrieved on: 
星期四, 三月 7, 2024

This is the first time that artesunate is demonstrated to be able to treat obesity in a non-human primate, suggesting its therapeutic potential as a drug for treating human obesity.

Key Points: 
  • This is the first time that artesunate is demonstrated to be able to treat obesity in a non-human primate, suggesting its therapeutic potential as a drug for treating human obesity.
  • However, patient compliance with exercise and dietary changes is often challenging, and many anti-obesity drugs are associated with adverse effects.
  • The researchers explored the therapeutic effect of artesunate on obesity using mice with diet-induced obesity.
  • "The research results provide hope for developing a novel treatment agent in response to the public health challenge of obesity, which warrants more extensive and effective interventions," he added.

New Chinese medicine drug developed by HKBU for myofibrillar myopathy granted orphan drug designation by FDA

Retrieved on: 
星期三, 一月 10, 2024

The drug has obtained the orphan drug designation from the US Food and Drug Administration (FDA), and is the first botanical drug in Hong Kong to receive this qualification.

Key Points: 
  • The drug has obtained the orphan drug designation from the US Food and Drug Administration (FDA), and is the first botanical drug in Hong Kong to receive this qualification.
  • The research team plans to submit an Investigational New Drug application to FDA in two years to conduct clinical trials.
  • Professor Bian Zhaoxiang, Associate Vice-President (Chinese Medicine Development) and Director of the Centre for Chinese Herbal Medicine Drug Development at HKBU, said: "CDD-2107 is the fruit of the integration of Chinese medicine theory and modern technology.
  • Receiving the orphan drug designation by FDA for CDD-2107 is an encouraging milestone and recognition of our team's dedication to scientific innovation."

New Chinese medicine drug developed by HKBU for myofibrillar myopathy granted orphan drug designation by FDA

Retrieved on: 
星期三, 一月 10, 2024

The drug has obtained the orphan drug designation from the US Food and Drug Administration (FDA), and is the first botanical drug in Hong Kong to receive this qualification.

Key Points: 
  • The drug has obtained the orphan drug designation from the US Food and Drug Administration (FDA), and is the first botanical drug in Hong Kong to receive this qualification.
  • The research team plans to submit an Investigational New Drug application to FDA in two years to conduct clinical trials.
  • Professor Bian Zhaoxiang, Associate Vice-President (Chinese Medicine Development) and Director of the Centre for Chinese Herbal Medicine Drug Development at HKBU, said: "CDD-2107 is the fruit of the integration of Chinese medicine theory and modern technology.
  • Receiving the orphan drug designation by FDA for CDD-2107 is an encouraging milestone and recognition of our team's dedication to scientific innovation."

Top AI experts share insights at HKUST-Greater Bay Area Association of Academicians symposium

Retrieved on: 
星期二, 十一月 28, 2023

HONG KONG, Nov. 28, 2023 /PRNewswire/ -- Top artificial intelligence (AI) experts, scholars and industry leaders from around the world have converged at a symposium in Hong Kong recently to share their knowledge, research and insights of ways to tap the potential of AI to improve the life of humankind.

Key Points: 
  • It will take years or decades for the development of artificial intelligence (AI) to reach human-level AI.
  • These are among the thought-provoking insights that Turing Prize winner Prof. Yann LeCun, hailed by the media as one of the "Godfathers of AI", elaborated in the symposium as a keynote speaker.
  • Entitled AI NEW HORIZONS 2023: A Symposium with Scientific Leaders, the event was jointly hosted by the Hong Kong University of Science and Technology (HKUST) and the Greater Bay Area Association of Academicians (GBAAA).
  • AI, Prof. LeCun said, will become a "shared infrastructure" in the future, like the Internet today.

Top AI experts share insights at HKUST-Greater Bay Area Association of Academicians symposium

Retrieved on: 
星期二, 十一月 28, 2023

HONG KONG, Nov. 28, 2023 /PRNewswire/ -- Top artificial intelligence (AI) experts, scholars and industry leaders from around the world have converged at a symposium in Hong Kong recently to share their knowledge, research and insights of ways to tap the potential of AI to improve the life of humankind.

Key Points: 
  • It will take years or decades for the development of artificial intelligence (AI) to reach human-level AI.
  • These are among the thought-provoking insights that Turing Prize winner Prof. Yann LeCun, hailed by the media as one of the "Godfathers of AI", elaborated in the symposium as a keynote speaker.
  • Entitled AI NEW HORIZONS 2023: A Symposium with Scientific Leaders, the event was jointly hosted by the Hong Kong University of Science and Technology (HKUST) and the Greater Bay Area Association of Academicians (GBAAA).
  • AI, Prof. LeCun said, will become a "shared infrastructure" in the future, like the Internet today.

Nubeva Technologies Provides Board Member Details and Corporate Updates

Retrieved on: 
星期五, 九月 22, 2023

SAN JOSE, Calif., Sept. 22, 2023 (GLOBE NEWSWIRE) -- Nubeva Technologies (TSX-V: NBVA, OTCQB: NBVAF), a technology innovation company specializing in decryption, today provides further details on its new board of director member and provides corporate updates.

Key Points: 
  • SAN JOSE, Calif., Sept. 22, 2023 (GLOBE NEWSWIRE) -- Nubeva Technologies (TSX-V: NBVA, OTCQB: NBVAF), a technology innovation company specializing in decryption, today provides further details on its new board of director member and provides corporate updates.
  • Francis has served as Head of HR Center of Excellence at SAP, VP of Product at Talkpush, and HR Director for a global manufacturer.
  • Their addition provides a fresh perspective to our organization,” said Randy Chou, CEO at Nubeva.
  • The board of Nubeva is actively engaged in a comprehensive review of the company.

Global Technology Marketing Executive to Drive Revenue and Brand Growth for Chief Outsiders Clients

Retrieved on: 
星期一, 六月 12, 2023

She will apply her extensive data, technology, fintech, payments, industrial, and business services industry experience to help clients accelerate revenue and brand growth as a Fractional CMO.

Key Points: 
  • She will apply her extensive data, technology, fintech, payments, industrial, and business services industry experience to help clients accelerate revenue and brand growth as a Fractional CMO.
  • “A dynamic global marketing executive, Pattie applies her expertise in growth marketing spanning Fortune 500 and PE-backed companies to accelerate growth for startups and mid-market companies,” said Clay Spitz, Managing Partner, Chief Outsiders.
  • At Chief Outsiders, Pattie works with the CEOs of data, technology, financial services, business services, and industrial companies to accelerate revenue and brand growth .
  • As Global Director of Marketing and Communications at Tyco International, she brought the Tyco Flow Control brand to life, leading brand strategy, brand architecture, and 360° brand marketing globally.

Reaching Out to Schools – Privacy Commissioner Attends the “Media and Information Literacy” Education Webinar

Retrieved on: 
星期六, 三月 18, 2023

The Privacy Commissioner for Personal Data (Privacy Commissioner), Ms Ada CHUNG Lai-ling, earlier attended the “Media and Information Literacy” education webinar organised by Sing Tao Daily and gave a presentation to over 260 principals and teachers of primary and secondary schools as well as parents on “Say ‘No’ to Cyberbullying and Doxxing”.

Key Points: 
  • The Privacy Commissioner for Personal Data (Privacy Commissioner), Ms Ada CHUNG Lai-ling, earlier attended the “Media and Information Literacy” education webinar organised by Sing Tao Daily and gave a presentation to over 260 principals and teachers of primary and secondary schools as well as parents on “Say ‘No’ to Cyberbullying and Doxxing”.
  • During the webinar, apart from explaining to participants how to handle cyberbullying behaviour, the Privacy Commissioner also highlighted the doxxing offences introduced by the Personal Data (Privacy) (Amendment) Ordinance 2021 and provided some practical advice on how to protect personal data privacy in the use of social media and instant messaging apps.
  • Please click here for the presentation deck (Chinese only).
  • The Privacy Commissioner, Ms Ada CHUNG Lai-ling (2nd from left), Editor in Chief of Sing Tao Daily and The Standard, Mr Ivan TONG Kam-piu (1st from left), Sing Tao New Media Business General Manager, Mr Ernest CHI Pan-year (1st from right), and Associate Professor of Practice Program, Department of Journalism, School of Communication, Hong Kong Baptist University, Ms Bonnie CHIU Lai-yu (2nd from right), gave presentations at the webinar.